Northwire Canada EditionTuesday, August 25, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%
Earnings

VitalHub Reports Fourth Quarter 2025 Results

By The Northwire Desk — AI Analysis Mar 18, 2026 · 18:23 VHI · 7.71 VITALHUB CORP. J
VHI · Price

Executive Summary

  • VitalHub reported a strong 2025 year, with ARR up 35% YoY to $96.1 M and total revenue up 52% YoY to $31.4 M for Q4 and $108.97 M for the full year.
  • Adjusted EBITDA rose 47% YoY to $7.43 M in Q4 (24% of revenue) and $26.55 M for the year (24% of revenue).
  • Cash and short‑term investments more than doubled to $119.2 M, supporting a robust balance sheet for further acquisitions.

Key Details

  • Annual Recurring Revenue (ARR) – $96,149,750 as of 31 Dec 2025 vs. $71,054,210 on 31 Dec 2024 (+35%).
  • Quarter‑end ARR growth – Q4 2025 ARR $96,149,750 vs. Q3 2025 $93,693,789 (+3%); driven by organic growth ($1.88 M) and FX gain ($0.57 M).
  • Revenue – Q4 2025: $31,390,374 (↑52% YoY); FY 2025: $108,966,918 (↑59% YoY).
  • Gross profit margin – FY 2025: 80% of revenue (down from 81% in FY 2024).
  • Net income – Q4 2025: $4.07 M vs. $0.79 M YoY; FY 2025: $6.11 M vs. $3.00 M YoY.
  • EBITDA – Q4 2025: $3.29 M (↑75% YoY); FY 2025: $14.63 M (↑47% YoY).
  • Adjusted EBITDA – Q4 2025: $7.43 M (24% of revenue, ↓1 ppt YoY); FY 2025: $26.55 M (24% of revenue, ↓2 ppt YoY).
  • Cash & short‑term investments – $119.18 M at year‑end 2025 vs. $56.57 M at year‑end 2024.
  • Deferred revenue – $45.43 M (up from $35.64 M).
  • Operating expense highlights (FY 2025):
  • General & admin: $22.46 M (21% of revenue, ↓11% YoY)
  • Sales & marketing: $10.28 M (9% of revenue, ↓59% YoY)
  • R&D: $28.95 M (27% of revenue, ↑102% YoY)
  • Non‑IFRS measures – ARR defined as annual renewable software license fees and maintenance services; adjusted EBITDA excludes share‑based compensation, acquisition integration costs, and contingent consideration adjustments.
  • Management commentary – CEO Dan Matlow highlighted the $100 M revenue milestone, ongoing M&A integration, AI‑driven product roadmap, and a strong balance sheet positioning VitalHub for further acquisitions in 2026.

Notable Quotes

“2025 was a milestone year for VitalHub, surpassing $100 million in revenue… We have a strong balance sheet as we consider acquisition opportunities of all sizes in our core and adjacent geographies.” – Dan Matlow, CEO

Materiality: Material – Positive (significant revenue growth, profitability improvement, and substantial cash position).

Read the original news release →

More from VITALHUB CORP. J

Jun 16, 2026 · 07:00

VitalHub Announces Deployments of Referral Management Solutions

Other May 07, 2026 · 17:55

Q1 Revenue Surges 47%

Earnings Apr 14, 2026 · 07:00

VitalHub Expands Ontario Footprint Amidst Valuation Compression

Other Mar 09, 2026 · 20:12

Vitalhub's Novari Health rolls out tech in Niagara

M&A / Property Mar 09, 2026 · 07:30

VitalHub Announces Novari Health AI-Enhanced Referral Management Deployment

Production / Operations Feb 20, 2026 · 07:00

VitalHub Announces Q4 2025 Conference Call Date

Earnings